[1] |
LV T, LI M, ZENG N, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population[J]. J Gastroenterol Hepatol, 2019, 34(10): 1676-1684. DOI: 10.1111/jgh.14746.
|
[2] |
MANNS MP, CZAJA AJ, GORHAM JD, et al. Diagnosis and management of autoimmune hepatitis[J]. Hepatology, 2010, 51(6): 2193-2213. DOI: 10.1002/hep.23584.
|
[3] |
WANG CW, GRAB J, TANA MM, et al. Outcomes of pregnancy in autoimmune hepatitis: A population-based study[J]. Hepatology, 2022, 75(1): 5-12. DOI: 10.1002/hep.32132.
|
[4] |
WESTBROOK RH, YEOMAN AD, KRIESE S, et al. Outcomes of pregnancy in women with autoimmune hepatitis[J]. J Autoimmun, 2012, 38(2-3): J239-J244. DOI: 10.1016/j.jaut.2011.12.002.
|
[5] |
WANG QX, MA X. Current status and perspectives of autoimmune hepatitis[J]. J Clin Hepatol, 2020, 36(4): 721-723. DOI: 10.3969/j.i ssn.1001-5256.2020.04.001.
王绮夏, 马雄. 自身免疫性肝炎的研究现状与展望[J]. 临床肝胆病杂志, 2020, 36(4): 721-723. DOI: 10.3969/j.issn.1001-5256.2020.04.001.
|
[6] |
DONG WD, ZHANG HR, LI R, et al. Role of regulatory T/T helper 17 cells in the pathogenesis of autoimmune hepatitis and related therapeutic targets[J]. J Clin Hepatol, 2021, 37(10): 2456-2460. DOI: 10.3969/j.issn.1001-5256.2021.10.042.
董雯迪, 张海蓉, 李瑞, 等. 调节性T淋巴细胞/辅助性T淋巴细胞17在自身免疫性肝炎发生发展中的作用机制及其相关治疗靶点[J]. 临床肝胆病杂志, 2021, 37(10): 2456-2460. DOI: 10.3969/j.issn.1001-5256.2021.10.042.
|
[7] |
ZHANG H, LIU Y, BIAN Z, et al. The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury[J]. J Autoimmun, 2014, 53: 55-66. DOI: 10.1016/j.jaut.2014.02.010.
|
[8] |
BOZWARD AG, WOOTTON GE, PODSTAWKA O, et al. Autoimmune hepatitis: Tolerogenic immunological state during pregnancy and immune escape in post-partum[J]. Front Immunol, 2020, 11: 591380. DOI: 10.3389/fimmu.2020.591380.
|
[9] |
RAHIM MN, RAN S, SHAH S, et al. Safety and efficacy of budesonide during pregnancy in women with autoimmune hepatitis[J]. Hepatology, 2021, 73(6): 2601-2606. DOI: 10.1002/hep.31634.
|
[10] |
AKBARI M, SHAH S, VELAYOS FS, et al. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease[J]. Inflamm Bowel Dis, 2013, 19(1): 15-22. DOI: 10.1002/ibd.22948.
|
[11] |
MACK CL, ADAMS D, ASSIS DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases[J]. Hepatology, 2020, 72(2): 671-722. DOI: 10.1002/hep.31065.
|
[12] |
WANG G, TANAKA A, ZHAO H, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis[J]. Hepatol Int, 2021, 15(2): 223-257. DOI: 10.1007/s12072-021-10170-1.
|
[13] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of autoimmune hepatitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 42-49. DOI: 10.3760/cma.j.cn112138-20211112-00796.
中华医学会肝病学分会. 自身免疫性肝炎诊断和治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 42-49. DOI: 10.3760/cma.j.cn112138-20211112-00796.
|
[14] |
BIGGIOGGERO M, BORGHI MO, GEROSA M, et al. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants[J]. Lupus, 2007, 16(8): 651-656. DOI: 10.1177/0961203307079569.
|
[15] |
CLARIS O, PICAUD JC, BRAZIER JL, et al. Pharmacokinetics of cyclosporin A in 16 newborn infants of renal or cardiac transplant mothers[J]. Dev Pharmacol Ther, 1993, 20(3-4): 180-185. DOI: 10.1159/000457560.
|
[16] |
FU JH. Analysis of the use of cyclosporin A to treat refractory immune recurrent spontaneous abortion[J]. Clin Exp Obstet Gynecol, 2015, 42(6): 739-742. https://pubmed.ncbi.nlm.nih.gov/26753475/
|
[17] |
BITTENCOURT PL, FARIAS AQ, PORTA G, et al. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background[J]. J Clin Gastroenterol, 2008, 42(3): 300-305. DOI: 10.1097/MCG.0b013e31802dbdfc.
|
[18] |
DENG BR, GUO LP, ZHOU L, et al. Progress of pregnancy research in patients with autoimmune hepatitis[J]. Chin J Dig, 2017, 37(4): 285-286. DOI: 10.3760/cma.j.issn.0254-1432.2017.04.016.
邓宝茹, 郭丽萍, 周璐, 等. 自身免疫性肝炎患者妊娠研究进展[J]. 中华消化杂志, 2017, 37(4): 285-286. DOI: 10.3760/cma.j.issn.0254-1432.2017.04.016.
|
[19] |
LEE NM, BRADY CW. Liver disease in pregnancy[J]. World J Gastroenterol, 2009, 15(8): 897-906. DOI: 10.3748/wjg.15.897.
|
[20] |
MIYAURA H, IWATA M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids[J]. J Immunol, 2002, 168(3): 1087-1094. DOI: 10.4049/jimmunol.168.3.1087.
|
[21] |
MAO G, WANG J, KANG Y, et al. Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice[J]. Endocrinology, 2010, 151(11): 5477-5488. DOI: 10.1210/en.2010-0426.
|
[22] |
BUCHEL E, van STEENBERGEN W, NEVENS F, et al. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery[J]. Am J Gastroenterol, 2002, 97(12): 3160-3165. DOI: 10.1111/j.1572-0241.2002.07124.x.
|
[23] |
PETERS MG. Management of autoimmune hepatitis in pregnant women[J]. Gastroenterol Hepatol (N Y), 2017, 13(8): 504-506. https://pubmed.ncbi.nlm.nih.gov/28867984/
|
[24] |
OLSEN K, HODSON J, RONCA V, et al. Type 2 autoimmune hepatitis and nonadherence to medication correlate with premature birth and risk of postpartum flare[J]. Hepatol Commun, 2021, 5(7): 1252-1264. DOI: 10.1002/hep4.1714.
|
[25] |
MANNS MP, LOHSE AW, VERGANI D. Autoimmune hepatitis— Update 2015[J]. J Hepatol, 2015, 62(1 Suppl): S100-S111. DOI: 10.1016/j.jhep.2015.03.005.
|
[26] |
BRAGA A, VASCONCELOS C, BRAGA J. Autoimmune hepatitis and pregnancy[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 68: 23-31. DOI: 10.1016/j.bpobgyn.2020.03.007.
|
[27] |
KOTHADIA JP, SHAH J. Autoimmune hepatitis and pregnancy[M]. Treasure Island (FL): StatPearls Publishing, 2022.
|
[28] |
JANIK MK, WUNSCH E, RASZEJA-WYSZOMIRSKA J, et al. Autoimmune hepatitis exerts a profound, negative effect on health-related quality of life: A prospective, single-centre study[J]. Liver Int, 2019, 39(1): 215-221. DOI: 10.1111/liv.13960.
|
[29] |
EL JAMALY H, ESLICK GD, WELTMAN M. Systematic review with meta-analysis: autoimmune hepatitis in pregnancy[J]. Scand J Gastroenterol, 2021, 56(10): 1194-1204. DOI: 10.1080/00365521.2021.1953127.
|
[30] |
ALUVIHARE VR, KALLIKOURDIS M, BETZ AG. Regulatory T cells mediate maternal tolerance to the fetus[J]. Nat Immunol, 2004, 5(3): 266-271. DOI: 10.1038/ni1037.
|
[31] |
SAMUEL D, RIORDAN S, STRASSER S, et al. Severe autoimmune hepatitis first presenting in the early post partum period[J]. Clin Gastroenterol Hepatol, 2004, 2(7): 622-624. DOI: 10.1016/s1542-3565(04)00245-9.
|
[32] |
GONZÁLEZ DA, DÍAZ BB, RODRÍGUEZ PÉREZ MDEL C, et al. Sex hormones and autoimmunity[J]. Immunol Lett, 2010, 133(1): 6-13. DOI: 10.1016/j.imlet.2010.07.001.
|
[33] |
LLOVET LP, HORTA D, ELIZ MG, et al. Presentation and outcomes of pregnancy in patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol, 2019, 17(13): 2819-2821. DOI: 10.1016/j.cgh.2018.12.030.
|
[34] |
CHRISTENSEN LA, DAHLERUP JF, NIELSEN MJ, et al. Azathioprine treatment during lactation[J]. Aliment Pharmacol Ther, 2008, 28(10): 1209-1213. DOI: 10.1111/j.1365-2036.2008.03843.x.
|
[35] |
ANGELBERGER S, REINISCH W, MESSERSCHMIDT A, et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding[J]. J Crohns Colitis, 2011, 5(2): 95-100. DOI: 10.1016/j.crohns.2010.10.005.
|